搜索
Abcellera Biologics Inc
ABCL添加自选
5.715USD
+0.025+0.44%
收盘 07-31 16:00（美东）报价延迟15分钟
1.74B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月14日 周四
更新时间: 5月14日 周四
持股股东
股东类型
持股股东
持股股东
占比
Thermopylae Holdings Ltd
18.38%
Baker Bros. Advisors LP
9.01%
Capital World Investors
4.38%
Two Sigma Investments, LP
3.52%
Lecault (Veronique)
3.15%
其他
61.56%
持股股东
持股股东
占比
Thermopylae Holdings Ltd
18.38%
Baker Bros. Advisors LP
9.01%
Capital World Investors
4.38%
Two Sigma Investments, LP
3.52%
Lecault (Veronique)
3.15%
其他
61.56%
股东类型
持股股东
占比
Corporation
18.39%
Hedge Fund
15.77%
Investment Advisor
11.92%
Research Firm
4.81%
Investment Advisor/Hedge Fund
4.44%
Individual Investor
4.22%
Bank and Trust
1.47%
Venture Capital
0.15%
Pension Fund
0.13%
其他
38.70%
机构持股
更新时间: 4月5日 周日
更新时间: 4月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2026Q1
323
131.69M
43.14%
-19.22M
2025Q4
315
112.27M
50.73%
-101.09K
2025Q3
340
112.51M
51.75%
-3.28M
2025Q2
368
115.12M
53.94%
-18.45M
2025Q1
420
133.63M
52.62%
-23.37M
2024Q4
441
121.95M
50.14%
+4.83M
2024Q3
440
121.95M
51.59%
-4.54M
2024Q2
439
127.07M
51.27%
-6.55M
2024Q1
432
134.44M
53.43%
-22.43M
2023Q4
425
138.44M
60.93%
-1.40M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Thermopylae Holdings Ltd
56.13M
18.52%
+215.46K
+0.39%
Feb 27, 2026
Baker Bros. Advisors LP
27.53M
9.08%
--
--
Dec 31, 2025
Capital World Investors
13.36M
4.41%
--
--
Dec 31, 2025
Two Sigma Investments, LP
10.76M
3.55%
+769.18K
+7.70%
Dec 31, 2025
Lecault (Veronique)
9.61M
3.17%
--
--
Apr 01, 2025
UBS Asset Management (Americas) LLC
5.00M
1.65%
+5.00M
--
Dec 31, 2025
Goldman Sachs & Company, Inc.
4.34M
1.43%
+4.09M
+1636.29%
Dec 31, 2025
UBS Switzerland AG
1.93M
0.64%
-540.41K
-21.86%
Dec 31, 2025
ArrowMark Colorado Holdings, LLC
4.11M
1.35%
--
--
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Genomics Immunology and Healthcare ETF
2.64%
Virtus LifeSci Biotech Clinical Trials ETF
1.19%
ProShares Ultra Nasdaq Biotechnology
0.16%
Invesco Nasdaq Biotechnology ETF
0.16%
SPDR S&P International Small Cap ETF
0.12%
iShares Biotechnology ETF
0.11%
Invesco RAFI Developed Mkts ex-US SM ETF
0.05%
Avantis US Small Cap Equity ETF
0.01%
SPDR Portfolio Developed World ex-US ETF
0.01%
Fidelity Nasdaq Composite Index ETF
0.01%
查看更多
iShares Genomics Immunology and Healthcare ETF
占比2.64%
Virtus LifeSci Biotech Clinical Trials ETF
占比1.19%
ProShares Ultra Nasdaq Biotechnology
占比0.16%
Invesco Nasdaq Biotechnology ETF
占比0.16%
SPDR S&P International Small Cap ETF
占比0.12%
iShares Biotechnology ETF
占比0.11%
Invesco RAFI Developed Mkts ex-US SM ETF
占比0.05%
Avantis US Small Cap Equity ETF
占比0.01%
SPDR Portfolio Developed World ex-US ETF
占比0.01%
Fidelity Nasdaq Composite Index ETF
占比0.01%